M.D. Anderson Cancer Center
1 registered trial on this site, 0 active. This page lists the trials this organization is registered as lead sponsor of, for the compounds covered on PeptideBlog.net. It is a registry listing, not an assessment of the company or its products.
Compounds covered
Registered trials
| Trial | Compound | Phase | Status | Sponsor | Enrolled | Primary completion | Registry updated |
|---|---|---|---|---|---|---|---|
| A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity NCT01262664 | Adipotide | Phase 1 | Terminated | M.D. Anderson Cancer Center | 4 | Jan 2, 2019 | Jan 4, 2019 |
Data: ClinicalTrials.gov, U.S. National Library of Medicine. See the full trial tracker.
